Targeting senescence with radioactive
Immunity activation
One‐two punch strategy
Radioactive (223)Ra/Ba single atom nanozymes
Senescence targeting engineering
Senolytics
Journal
Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316
Informations de publication
Date de publication:
23 Oct 2024
23 Oct 2024
Historique:
received:
15
08
2024
revised:
13
10
2024
accepted:
22
10
2024
medline:
27
10
2024
pubmed:
27
10
2024
entrez:
26
10
2024
Statut:
aheadofprint
Résumé
Senescent cells are characterized by a persistent cessation of their cell cycle, rendering them valuable targets for anti-tumor strategies in cancer treatment. Numerous studies have explored induced senescence as a promising approach in tumor therapy. Nevertheless, these treatments often come with drawbacks, including adverse side effects and weaker senescence-inducing effects. To address these challenges, we synthesized
Identifiants
pubmed: 39461062
pii: S0142-9612(24)00449-6
doi: 10.1016/j.biomaterials.2024.122915
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
122915Informations de copyright
Copyright © 2024 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no conflict of interest.